SBIR Phase I: AI-Enabled Discovery of Multi-Omics Biomarkers Applicable to Broad Cancer Po — NSF Award to SOSTOS LLC (WV, $305,000
The broader/commercial impact of this Small Business Innovation Research (SBIR) Phase I project is to deliver a novel software product for oncologists to browse biomarkers potentially applicable to large patient populations. The proposed software discovers novel biomarkers predictive of therapeutic responses for improv
| Award title | SBIR Phase I: AI-Enabled Discovery of Multi-Omics Biomarkers Applicable to Broad Cancer Po |
|---|---|
| Award ID | 2434965 |
| Awardee | SOSTOS LLC |
| City | MORGANTOWN |
| State | WV |
| Amount obligated | $305,000 |
| Principal investigator | Qing Ye |
| Program | SBIR Phase I |
| Start date | 06/01/2025 |
| Abstract | The broader/commercial impact of this Small Business Innovation Research (SBIR) Phase I project is to deliver a novel software product for oncologists to browse biomarkers potentially applicable to large patient populations. The proposed software discovers novel biomarkers predictive of therapeutic responses for improved personalized cancer treatment and patient survival. This software will also facilitate the development of gene assays by biotech companies with reduced research and development |
| Source | NSF Awards |
$799/mo
Try NSFGrants →